Pharmacological Actions of Indoxyl Sulfate and AST-120 That Should Be Recognized for the Strategic Treatment of Patients with Chronic Kidney Disease

Pharmacological Actions of Indoxyl Sulfate and AST-120 That Should Be Recognized for the Strategic Treatment of Patients with Chronic Kidney Disease

Daisuke Nagata, Hiromichi Yoshizawa Division of Nephrology, Department of Internal Medicine, Jichi Medical University, Tochigi, JapanCorrespondence: Daisuke Nagata Tel +81 285 58 7346Fax +81 285 44 4869Email nagatad@jichi.ac.jpAbstract: Although there are many uremic substances in the body, the most...

Full description

Bibliographic Details
Main Authors: Nagata D, Yoshizawa H
Format: Article
Language:English
Published: Dove Medical Press 2020-12-01
Series:International Journal of Nephrology and Renovascular Disease
Subjects:
chronic kidney disease (ckd)
uremic toxin
indoxyl sulfate (is)
ast-120
hemodialysis
medication adherence
Online Access:https://www.dovepress.com/pharmacological-actions-of-indoxyl-sulfate-and-ast-120-that-should-be--peer-reviewed-article-IJNRD

Internet

https://www.dovepress.com/pharmacological-actions-of-indoxyl-sulfate-and-ast-120-that-should-be--peer-reviewed-article-IJNRD

Similar Items